Skip to main content
Log in

Minimization of inflammation in the treatment of bladder tumors by intravesical instillation of Adriamycin

  • Bladder Cancer, Adriamycin
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

The purpose of this trial was to minimize local infalammation caused by intravesical instillation of antitumor agents, especially Adriamycin, in the treatment of bladder tumor. Tranexamic acid was chosen as the solvent vehicle for Adriamycin and IV bolus injection of an antiallergic drug, Stronger neo-minophagen C, was given at the time of each instillation.

Of 81 cases scheduled for Adriamycin instillation therapy, nine cases (11.1%) dropped out due to severe bladder inflammation, while 17 other cases (21%) experienced local side-effects which were tolerated. Of 62 evaluable cases in whom more than eight instillations were performed, complete regression was observed in six cases (9.7%) and partial regression in 20 cases (32.3%).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Arcamone F (1981) The isolation of doxorubicin. In: Doxorubicin. Academic Press, New York, p 17

    Google Scholar 

  2. Edsmyr F, Berlin T, Bowman J, Duchek M, Esposti PL, Gustafsson H, Wijstrom H (1980) Intravesical treatment with adriamycin in patients with superficial bladder tumor. In: Bladder tumors and other topics in urological oncology. Plenum Press, New York, p 321

    Google Scholar 

  3. Jones HC, Swinney J (1961) Thiotepa in the treatment of tumors of the bladder. Lancet II: 615

    Google Scholar 

  4. Kyushu Cooperative Urological Research Group (1974) Effects of intravesical instillation of mitomycin C on the recurrence rate of bladder tumors. Nishinihon Journal of Urology 36: 535

    Google Scholar 

  5. Middleman E, Luce JK, Frei E (1971) Clinical trials with adriamycin. Cancer 28: 844

    Google Scholar 

  6. Niijima T, Matsumura Y, Kondo K, Katayama Y, Ozaki Y (1975) Intravesical instillation of adriamycin for the treatment of tumor of the bladder; The preliminary report. Acta Urologica Japonica 21: 233

    Google Scholar 

  7. Oravisto KJ (1965) Topical use of thio-TEPA for tumours of the bladder. Urol Int 20: 23

    Google Scholar 

  8. Ozaki Y (1977) Bladder instillation of adriamycin in the treatment of bladder tumors. 1. Clinical results. Jap J Urol 68: 934

    Google Scholar 

  9. Page BH, Levison VB, Curwen MP (1978) The site of recurrence of non-infiltrating bladder tumours. Br J Urol 50: 237

    Google Scholar 

  10. Saito S, Ohi Y, Tomiyama T, Jinnouchi K, Shinpuku T, Tomari S, Tsunoda K (1968) Intracavital chemotherapy of bladder tumor. Dermatology and Urology 30: 337

    Google Scholar 

  11. Semple JE (1948) Papillomata of bladder treated with podophyllin, preliminary report. Br Med J I: 235

    Google Scholar 

  12. Tomiyama T (1972) Effects of intravesical instillation of antitumor agents on bladder cancer. Jpn J Urol 63: 497

    Google Scholar 

  13. Tsunoda K, Ohi Y, Okamoto K (1978) Prophylactic effect of combined regimen of intravesical instillation of mitomycin C and administration of SLA on recurrence of bladder tumor. Nishinihon Journal of Urology 40: 458

    Google Scholar 

  14. Uyama K, Kagawa S (1977) Experimental and clinical study of adriamycin for bladder cancer. Nishinihon Journal of Urology 39: 916

    Google Scholar 

  15. Wescott JW (1966) The prophylactic use of Thio-TEPA in transitional cell carcinoma of the bladder. J Urol 96: 913

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ohi, Y., Okamoto, K., Kawabata, T. et al. Minimization of inflammation in the treatment of bladder tumors by intravesical instillation of Adriamycin. Cancer Chemother. Pharmacol. 11 (Suppl 1), S83–S88 (1983). https://doi.org/10.1007/BF00256726

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00256726

Keywords

Navigation